Sickle Cell Disease and a Vaso-Occlusive Crisis: Opioid Dosing, Stigma, and Discharge Safety
A 28-year-old woman with HbSS disease presents to the emergency department with 2 days of severe back and leg pain, consistent with her usual vaso-occlusive crises. She is afebrile, oxygen saturation 96% on room air, and has no chest pain or shortness of breath. She reports that she has been 'treated like a drug seeker' at this hospital before. Her home regimen is hydroxyurea and extended-release morphine 30 mg twice daily, with oxycodone for breakthrough pain. The ED resident gives one dose of IV morphine and tells her 'we don't refill narcotics here.' She asks to speak to someone about her care.
1. What is the appropriate acute management of her vaso-occlusive crisis, and how should you respond to the resident's statement?
Read the worked answer
Acute management.
- Prompt, adequately dosed parenteral opioid analgesia - typically IV opioids titrated to effect within 30 minutes, then scheduled (not PRN-only) dosing, with reassessment. Under-dosing prolongs crisis and is a common failure.
- Aggressive hydration (oral or IV, avoiding fluid overload), and incentive spirometry.
- Assess for acute chest syndrome (fever, hypoxia, chest pain, infiltrate) - she has none currently but must be monitored.
- Consider ketorolac as an adjunct if renal function permits; avoid meperidine.
- Continue hydroxyurea unless contraindicated.
Responding to the resident. The statement reflects a misconception: sickle cell patients with chronic opioid therapy are at risk of withdrawal and under-treatment, not 'drug seeking.' Untreated pain is a patient-safety issue. Correct the framing privately and in a non-punitive way, and escalate to the attending. The patient's prior experience of stigma is a communication failure that must be acknowledged.
2. How do you address her experience of stigma and rebuild trust, and what communication skills matter here?
Read the worked answer
Acknowledge and validate. 'I'm sorry that happened. You deserve to be treated with respect, and your pain is real.' Do not defend the institution or minimize.
Use patient-centered communication.
- Sit down, make eye contact, and ask open-ended questions about her usual crisis pattern and what has worked before.
- Use teach-back to confirm understanding of the plan.
- Explicitly state that you believe her pain and that you will treat it.
- Ask what would make this hospitalization better for her.
Avoid stigmatizing language. Do not use 'frequent flyer,' 'drug-seeking,' or 'non-compliant.' Use 'patient with sickle cell disease admitted for vaso-occlusive crisis.'
System-level action. Consider a brief note in the chart documenting her individualized pain plan, and flag it so future clinicians see it. Consider involving a patient advocate or hematology consult early.
3. What discharge planning and systems issues should you address to prevent readmission and ensure safe opioid continuation?
Read the worked answer
Discharge planning.
- Do not discharge until pain is controlled on oral therapy and she is clinically stable (afebrile, no hypoxia, tolerating oral intake).
- Reconcile her home opioids and provide a clear written plan: baseline extended-release morphine, breakthrough oxycodone, and instructions for what to do if pain escalates.
- Prescribe enough to bridge to her hematology follow-up; coordinate with her outpatient hematologist.
Systems issues.
- Document an individualized pain plan in the EHR (home doses, prior effective regimens) so future ED visits don't restart from zero.
- Use the state prescription drug monitoring program appropriately, not as a gatekeeping tool.
- Refer to a sickle cell day hospital or infusion center if available to avoid ED visits.
- Ensure hydroxyurea adherence and consider referral for disease-modifying therapy discussion.
- Close the loop: schedule follow-up before discharge and confirm transportation.